Deep-Dive Due Diligence AI Generated Report on Tenon Medical, Inc. Common Stock (TNON)
Welcome to ScanScor. What you're reading is not just a stock summary -- it's a real-time, AI-generated due diligence session crafted from live news, financial data, insider trading activity, SEC filings, and live market momentum.
These reports are generated using OpenAI's GPT-based analysis engine, guided by tightly structured prompts and expert-level data ingestion. Every insight below was assembled to help you understand the forces behind today's market movers.
Disclaimer: This report is for informational purposes only. It does not constitute financial advice. Always do your own research before making any investment.
TNON_OUT_1 [2025-03-24 07:41:30 -0400] 2095 Bytes | 578 tokens | Cum: 578 tkns (7.22% of 8k)
==========================================================================
You're the expert here today. So, I pulled together a bunch of data for you to look over real fast. I'm looking at high-performance stocks today and Tenon Medical (TNON) hit my radar screen, up to 1.36 from a prev close of 1 Do you think its got more juice or is it lacking potential? It's 7:41:29 AM on Mon Mar 24, 2025 -0400 and I have to decide: buy or sell!
Here's the first list of news for Tenon Medical:
C1 - Mar-20-25 06:40PM - Tenon Medical, Inc. (TNON) Q4 2024 Earnings Call Transcript
C2 - Mar-20-25 06:40PM 04:05PM - Tenon Medical Reports Fourth Quarter and Full Year 2024 Financial Results
C3 - Mar-11-25 03:40PM - Tenon Medical, Inc. Announces a Warrant Inducement Transaction for $3.0 Million in Gross Proceeds
C4 - Mar-10-25 04:05PM - Tenon Medical(R) Receives Approval for Notice of Allowance from the European Patent Office
C5 - Mar-07-25 08:00AM - Tenon Medical, Inc. Announces Timing of Fourth Quarter and Full Year 2024 Financial Results
C6 - Jan-09-25 08:00AM - Tenon Medical(R) to Host Meetings During the 2025 J.P. Morgan Healthcare Conference in San Francisco
C7 - Nov-13-24 04:05PM - Tenon Medical Reports Third Quarter 2024 Financial Results
C8 - Oct-30-24 04:05PM - Tenon Medical Announces Initial Clinical Cases Successfully Completed with Company's New Catamaran(R) SE SI Joint Fusion System
ONLY 3 RULES for AI:
==============
1) I am a document retrieval system. You are the analyst-investigator.
2) You can request items from my lists to get more info on Tenon Medical (TNON)
3) AFTER requesting and reading News and SEC filings you'll write a summary, set a score, high price target and headline.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!
Please request a document, read, summarize and score. Say something like "C1".
TNON_IN_2 [2025-03-24 07:41:30 -0400] 2 Bytes | 2 tokens | Cum: 580 tkns (7.25% of 8k)
==========================================================================
C2
TNON_OUT_3 [2025-03-24 07:41:35 -0400] 451 Bytes | 134 tokens | Cum: 714 tkns (8.92% of 8k)
==========================================================================
Showing C2 (chunk 1 of 1): C2:
**Tenon Medical Reports Fourth Quarter and Full Year 2024 Financial Results**
Date: Mar-20-25 06:40PM 04:05PM
Source: (ACCESSWIRE)
URL: https://www.accesswire.com/viewarticle.aspx?id=1003009
Error fetching article: 403 Client Error: Forbidden for url: https://www.accesswire.com/viewarticle.aspx?id=1003009
-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)
TNON_IN_4 [2025-03-24 07:41:35 -0400] 227 Bytes | 47 tokens | Cum: 761 tkns (9.51% of 8k)
==========================================================================
As a financial analyst, I'm unable to provide a summary or analysis of Tenon Medical's fourth quarter and full year 2024 financial results as mentioned in the article due to an error in fetching the details from the source URL.
TNON_OUT_5 [2025-03-24 07:41:37 -0400] 948 Bytes | 285 tokens | Cum: 1046 tkns (13.08% of 8k)
==========================================================================
We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.
A1 - 2025-03-20T20:28:00Z - Tenon Medical GAAP EPS of -$11.26, revenue of $3.28M misses by $0.13M...
A2 - 2025-03-20T20:14:00Z - Tenon Medical, Inc.: Tenon Medical Reports Fourth Quarter and Full Year 2024 Financial Results...
A3 - 2025-03-20T20:08:23Z - Tenon Medical Reports Fourth Quarter and Full Year 2024 Financial Results...
A4 - 2025-03-20T20:07:12Z - Tenon Medical Reports Fourth Quarter and Full Year 2024 Financial Results...
A5 - 2025-03-20T08:32:15Z - Earnings Scheduled For March 20, 2025 - Accenture (NYSE:ACN), Adaptimmune Therapeutics (NASDAQ:ADAP)...
Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.
TNON_IN_6 [2025-03-24 07:41:37 -0400] 2 Bytes | 2 tokens | Cum: 1048 tkns (13.10% of 8k)
==========================================================================
A1
TNON_OUT_7 [2025-03-24 07:41:43 -0400] 812 Bytes | 262 tokens | Cum: 1310 tkns (16.38% of 8k)
==========================================================================
Showing A1 (chunk 1 of 1): A1:
**Tenon Medical GAAP EPS of -$11.26, revenue of $3.28M misses by $0.13M**Date: 2025-03-20Source: {'uri': 'seekingalpha.com', 'dataType': 'news', 'title': 'Seeking Alpha'}URL: https://seekingalpha.com/news/4423157-tenon-medical-gaap-eps-of-1126-revenue-of-328m-misses-by-013mTenon Medical press release (NASDAQ:TNON): FY GAAP EPS of -$11.26. Revenue of $3.28M (+11.9% Y/Y) misses by $0.13M. As of December 31, 2024, cash and cash equivalents totaled $6.5 million, as compared to $2.4 million as of December 31, 2023.
More on Tenon Medical
Seeking Alpha's Quant Rating on Tenon Medical Historical earnings data for Tenon Medical Financial information for Tenon Medical
-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)
TNON_IN_8 [2025-03-24 07:41:43 -0400] 354 Bytes | 101 tokens | Cum: 1411 tkns (17.64% of 8k)
==========================================================================
Tenon Medical has announced its financial results, disclosing a FY GAAP EPS of -$11.26. The company's revenue stood at $3.28M, marking a +11.9% YoY increase, but fell short of expectations by $0.13M. As of the end of 2024, Tenon Medical reported cash and cash equivalents amounting to $6.5M, a significant rise from the $2.4M recorded at the end of 2023.
TNON_OUT_9 [2025-03-24 07:41:44 -0400] 949 Bytes | 303 tokens | Cum: 1714 tkns (21.43% of 8k)
==========================================================================
This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!
B1 - 2024-03-13T12:24:11Z - Why SurgePays Shares Are Trading Lower By Around 15%; Here Are 20 Stocks Moving Premarket
B2 - 2023-11-13T18:08:54Z - Why Edible Garden Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
B3 - 2023-11-07T13:28:51Z - Why Alteryx Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
B4 - 2023-11-03T17:26:11Z - Why Fortinet Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Friday's Mid-Day Session
B5 - 2023-11-03T16:12:08Z - Dow Surges Over 200 Points; ISM Services PMI Falls In October
B6 - 2023-11-03T14:02:16Z - Nasdaq Gains 1%; US Adds 150,000 Jobs In October
Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.
TNON_IN_10 [2025-03-24 07:41:45 -0400] 2 Bytes | 2 tokens | Cum: 1716 tkns (21.45% of 8k)
==========================================================================
B1
TNON_OUT_11 [2025-03-24 07:41:52 -0400] 1042 Bytes | 287 tokens | Cum: 2003 tkns (25.04% of 8k)
==========================================================================
Showing B1 (chunk 1 of 2): B1:
**Why SurgePays Shares Are Trading Lower By Around 15%; Here Are 20 Stocks Moving Premarket**Date: Unknown DateSource: Unknown SourceURL: https://www.benzinga.com/news/24/03/37656479/why-surgepays-shares-are-trading-lower-by-around-15-here-are-20-stocks-moving-premarketShares of SurgePays, Inc. (NASDAQ: SURG) fell sharply in today’s pre-market trading after the company reported worse-than-expected fourth-quarter financial results.
Surgepays posted GAAP earnings of 19 cents per share, missing market estimates of 41 cents per share. The company’s quarterly sales came in at $32.318 million versus expectations of $33.521 million, according to data from Benzinga Pro.
SurgePays shares dipped 14.6% to $5.97 in pre-market trading
Here are some other stocks moving in pre-market trading.
Gainers
NuCana plc (NASDAQ: NCNA) gained 99.6% to $0.7806 in pre-market trading after the company was gr
-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)
TNON_IN_12 [2025-03-24 07:41:52 -0400] 340 Bytes | 80 tokens | Cum: 2083 tkns (26.04% of 8k)
==========================================================================
SurgePays, Inc.'s shares fell by approximately 15% in pre-market trading due to worse-than-expected Q4 financial results. The company reported GAAP earnings of 19 cents per share, below the market expectation of 41 cents per share. Furthermore, SurgePays' quarterly sales were $32.318 million, falling short of the expected $33.521 million.
TNON_OUT_13 [2025-03-24 07:41:54 -0400] 620 Bytes | 181 tokens | Cum: 2264 tkns (28.30% of 8k)
==========================================================================
Showing B1 (chunk 2 of 2): anted U.S. Patent #11925658 for "Phosphoramidate Derivatives For Use In The Treatment Of Cancer; Especially In The Treatment Where The Patient Shows Resistance"
ShiftPixy, Inc. (NASDAQ: PIXY) shares rose 50% to $4.71 in pre-market trading after dipping over 19% on Tuesday.
Tenon Medical, Inc. (NASDAQ: TNON) rose 48.2% to $2.15 in pre-market trading after the company reported better-than-expected fourth-quarter GAAP EPS results.
Minim, Inc. (NASDAQ: MINM) gained 39.8% to ...
-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)
TNON_IN_14 [2025-03-24 07:41:54 -0400] 3 Bytes | 2 tokens | Cum: 2266 tkns (28.32% of 8k)
==========================================================================
MOR
TNON_OUT_15 [2025-03-24 07:41:56 -0400] 1097 Bytes | 307 tokens | Cum: 2573 tkns (32.16% of 8k)
==========================================================================
This is our list of SEC filings.
If empty, the search returned no recent filings.
S1 - 2025-03-12 8-K Item 1.01. Entry into a Material Definitive Agrmt.
On March 11, 2025, Tenon Medical, Inc. (the Company) entered into a warrant exercise inducement offer letter agreement (the Inducement Letter) with a certain holder (the Holder) of outstanding Common Stock purchase warrants...
S2 - 2024-11-14 10-Q PART I FIN INFO
ITEM 1. Condensed Cons Fin Stmnts (Unaudited)
Tenon Medical, Inc.
Condensed Cons Balance Sheets (Unaudited)
(In thousands, except share data)
September 30, December 31, 2024 2023 Assets Curr assets: Cash and ca...
S3 - 2024-09-17 8-K Item 1.01 Entry into a Material Definitive Agrmt.
On September 12, 2024, Tenon Medical, Inc. (the Company) entered into a placement agency agreement (the Placement Agency Agrmt) with A.G.P./Alliance Global Partners (the Placement Agent), and a securities purchase agreem...
Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.
TNON_IN_16 [2025-03-24 07:41:56 -0400] 2 Bytes | 2 tokens | Cum: 2575 tkns (32.19% of 8k)
==========================================================================
S1
TNON_OUT_17 [2025-03-24 07:41:58 -0400] 1038 Bytes | 268 tokens | Cum: 2843 tkns (35.54% of 8k)
==========================================================================
Showing S1 (chunk 1 of 5): S1:
Item 1.01. Entry into a Material Definitive Agreement.
On March 11, 2025, Tenon Medical, Inc. (the Company) entered into a warrant exercise inducement offer letter agreement (the Inducement Letter) with a certain holder (the Holder) of outstanding Common Stock purchase warrants exercisable for up to an aggregate of 2,445,700 shares (the Existing Warrants) of the Companys common stock, par value $0.001 per share (the Common Stock), which Existing Warrants were issued by the Company on September 16, 2024, and were originally exercisable at an exercise price of $4.28 per share.
Pursuant to the Inducement Letter, the Holder agreed to exercise the Existing Warrants for cash at a reduced exercise price of $1.25 per share in consideration for the Companys agreement to issue (i) new unregistered five-year warrants (the Series C-1 Warrants) to purchase up to an aggregate of 2,445,700 share
-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)
TNON_IN_18 [2025-03-24 07:41:58 -0400] 3 Bytes | 2 tokens | Cum: 2845 tkns (35.56% of 8k)
==========================================================================
MOR
TNON_OUT_19 [2025-03-24 07:42:00 -0400] 1038 Bytes | 252 tokens | Cum: 3097 tkns (38.71% of 8k)
==========================================================================
Showing S1 (chunk 2 of 5): s of Common Stock at an exercise price of $1.25 per share and (ii) new unregistered three-year warrants (the Series C-2 Warrants, and together with the Series C-1 Warrants, the New Warrants) to purchase up to an aggregate of 1,222,850 shares of Common Stock at an exercise price of $1.25 per share (the Inducement Transaction). The New Warrants are not exercisable without approval by our stockholders (Stockholder Approval), which, pursuant to the Inducement Letter, we are required to obtain at a meeting of our stockholders no later than 165 days after the consummation of the Inducement Transaction. The Series C-1 Warrants will be exercisable five years from the date on which Stockholder Approval is obtained, and the Series C-2 Warrants will be exercisable three years from the date on which Stockholder Approval is obtained.
The Company entered into a financial advisory agreement (the Fina
-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)
TNON_IN_20 [2025-03-24 07:42:00 -0400] 3 Bytes | 2 tokens | Cum: 3099 tkns (38.74% of 8k)
==========================================================================
NEX
TNON_OUT_21 [2025-03-24 07:42:13 -0400] 4319 Bytes | 1232 tokens | Cum: 4331 tkns (54.14% of 8k)
==========================================================================
This is our set of metrics.
Please analyze the numbers.
+---------------------+-----------------------+---------------------+------------------------+------------------------+-------------------------+
| Volume: 154,436 | SMA50: -31.62% | Market Cap: 3.14M | Option/Short: No / Yes | Sales past 5Y: 238.26% | Sales Surprise: -11.21% |
+---------------------+-----------------------+---------------------+------------------------+------------------------+-------------------------+
| Avg Volume: 934.86K | SMA200: -70.04% | Shs Outstand: 3.14M | Short Float: 5.29% | Employees: 21 | EPS Surprise: 379.31% |
+---------------------+-----------------------+---------------------+------------------------+------------------------+-------------------------+
| Rel Volume: 0.15 | Perf Week: 1.45% | Shs Float: 3.14M | Short Ratio: 0.18 | Debt/Eq: 0.07 | P/E: - |
+---------------------+-----------------------+---------------------+------------------------+------------------------+-------------------------+
| RSI (14): 36.49 | Perf Month: -31.50% | Inst Own: 2.76% | Short Interest: 0.17M | Sales Y/Y TTM: 11.92% | Earnings: Mar 20 AMC |
+---------------------+-----------------------+---------------------+------------------------+------------------------+-------------------------+
| ATR (14): 0.15 | Perf Quarter: -47.64% | Insider Own: 0.00% | Beta: 1.90 | ROE: -405.19% | |
+---------------------+-----------------------+---------------------+------------------------+------------------------+-------------------------+
| SMA20: -19.08% | Index: - | Insider Trans: - | Sales Q/Q: -4.70% | ROI: -223.71% | |
+---------------------+-----------------------+---------------------+------------------------+------------------------+-------------------------+
The next section covers any insider trading.
If this section may be blank due to no recent filings.
[Company Financial Summary]
[Company Details]
Name: Tenon Medical, Inc. Common Stock
Market Cap: 3136589.0
Shares Outstanding: 3136589
Sector: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 887000, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -3184000.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A
[Price Metrics - Last 30 Days]
Latest Close: 1
Average Volume: 2569860.5
30-Day High: 1.51
30-Day Low: 0.9857
[Detailed Financials: Q3 2024]
- Total Assets: $13,039,000.0
- Total Liabilities: $4,848,000.0
- Total Equity: $8,191,000.0
- Current Assets: $11,188,000.0
- Current Liabilities: $3,178,000.0
[Income Statement: Q3 2024]
- Revenue: $887,000.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -3.63
[Cash Flow Statement: Q3 2024]
- Net Cash Flow: $7,194,000.0
[Detailed Financials: Q2 2024]
- Total Assets: $6,006,000.0
- Total Liabilities: $5,174,000.0
- Total Equity: $832,000
- Current Assets: $4,087,000.0
- Current Liabilities: $3,403,000.0
[Income Statement: Q2 2024]
- Revenue: $901,000.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -1.02
[Cash Flow Statement: Q2 2024]
- Net Cash Flow: $-2,420,000.0
==== END OF FINANCIAL REPORT ====
You are now requested to make a summary analysis.
Save explaining why you didn't have enough information for the final survey.
Now, complete this report with the following:
1) Brief Summary: explain your findings in succinct wording.
2) MARKET_SCORE: If you calculate a 92% likelihood of an upward moves, say: MARKET_SCORE[92]
3) PRICE_TARGET: If you think the high today will be 50% higher, add to the price.
Eg., If the current price is $5.00, add 50%. Thus, PRICE_TARGET[$7.50] -- It should be at or above the current price.
4) Provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-12 words headline for news story, distilled from summary]
1) Brief Summary, 2) MARKET_SCORE, 3) PRICE_TARGET, and 4) AI_RPT_HEADLINE
TNON_IN_22 [2025-03-24 07:42:13 -0400] 975 Bytes | 234 tokens | Cum: 4565 tkns (57.06% of 8k)
==========================================================================
1) Brief Summary: Tenon Medical, Inc. is a small-cap company in the surgical and medical instruments and apparatus sector. The company has seen significant sales growth over the past 5 years (+238.26%). However, its performance in the short term seems quite negative. With a high short float (5.29%) and negative sales surprises (-11.21%), it seems like the market is bearish on the company. The company's debt to equity ratio is quite low (0.07), which is a positive sign. Their earnings per share (EPS) has shown a significant surprise of 379.31%, which could be a potential catalyst for the stock's price.
2) MARKET_SCORE[45]: Given the mixed indicators, there seems to be a 45% likelihood of an upward move.
3) PRICE_TARGET[$1.50]: Considering the current price of $1 and the potential catalyst of the EPS surprise, the target price could be around $1.50, a 50% increase from the current price.
4) AI_RPT_HEADLINE: "Tenon Medical: A Bumpy Ride with Potential Upside."
TNON_OUT_23 [2025-03-24 07:42:16 -0400] 676 Bytes | 167 tokens | Cum: 4732 tkns (59.15% of 8k)
==========================================================================
Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes
-> X3 <- More SEC Insider Trading (Form 3, 4, 5) Direct buys/sells from executives and institutions
-> X4 <- Broader sector & market news
-> X5 <- Your past analysis on similar companies (specify metrics)
-> X6 <- More financial metrics
-> X7 <- Your past analysis on this exact company
-> X8 <- Something altogether different (explain...)
TNON_IN_24 [2025-03-24 07:42:16 -0400] 94 Bytes | 28 tokens | Cum: 4760 tkns (59.50% of 8k)
==========================================================================
-> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes
TNON_IN_25 [2025-03-24 07:42:16 -0400] 126 Bytes | 29 tokens | Cum: 4789 tkns (59.86% of 8k)
==========================================================================
====================================
[2025-03-24 04:42:16] # Analysis Completed
Elapsed Time: 48.19 seconds